By Lawrence White

Asia-Pacific takeover volumes hit a record in the first half of 2014, driven by a surge in dealmaking in Australia and bankers expect the buying spree from China's private tech companies and reform of the state sector to boost second-half activity.

Announced M&A volume in the Asia-Pacific region in the first half rose 67 percent from a year ago to $378 billion, preliminary data from Thomson Reuters data show, the highest volume on record for the equivalent period. The record comes amid a boom in global M&A as improving CEO confidence and strong cash positions held by corporations drove a spate of mega-deals in pharmaceutical industries.

"This year has seen an increase in risk appetite driving a broader mix of real M&A deals, across India, Australia and China and across industry sectors, which makes us very optimistic for the rest of the year," said Richard Campbell-Breeden, chairman of the M&A group for Asia-Pacific at Goldman Sachs Group.

Australasia saw 19 deals worth more than $1 billion, compared with just two in the same period last year, with the real estate, industrials, consumer and healthcare sectors particularly active amid improving market conditions.

"The very significant rebound in deal activity in Australia is the result of a release of pent-up demand, the fact that valuations have stabilised, and greater boardroom confidence," said Colin Banfield, head of M&A Asia-Pacific at Citigroup.

Boutique investment bank Somerley Ltd snatched the top spot for all announced Asia-Pacific mergers, almost solely on the strength of its advisory work for the massive $36 billion purchase of assets by China's CITIC Pacific Ltd from its state-owned parent.

That deal forms part of the broader theme of China's state-owned enterprises beginning to restructure amid slowing growth at home and the government's desire for consolidation in key sectors.

The high variance in fees paid for deals in Asia means there is often little correlation between a bank's ranking on the tables for volume of deals done and for fees earned, say M&A bankers in the region.

Goldman Sachs Group Inc claimed the top spot for fees earned from Asia-Pacific M&A in the first half of the year, according to estimated data from Thomson Reuters and Freeman Consulting.

China tech spree

China's Internet giants have been on a buying spree this year. Top deals include Alibaba Group Holding Ltd's $1.2 billion investment in the merged video platform Youku Tudou, and JD.com Inc's almost $2 billion investment in Alibaba rival Tencent Holdings.

"The slew of deals in the China tech sector is a natural result of the need for consolidation as the leading players seek to aggregate content for China's Internet users," said Citi's Banfield.

In addition to being Asia's top M&A fee-winner, Goldman Sachs also tops the league tables for equity capital markets, ahead of UBS and Citi. But stock volatility took a toll on ECM volumes, with Asia-Pacific tally falling marginally to $87.5 billion in the first half, from $89.3 billion from a year ago.

Asia will miss out, however, on the year's likely plum equity deal as Alibaba abandoned plans to list in Hong Kong in favour of a U.S. IPO later this year.

"It was a disappointing outcome for Hong Kong because Alibaba's listing there would have had a gravity effect, pulling more companies to the market," said Fan Bao, chairman and chief executive officer of boutique investment bank China Renaissance.

 

Related Articles

方达、年利达、A&O Shearman助力中国财政部发行20亿欧元主权债券(ZH/EN)

中国财政部在法国巴黎成功簿记发行20亿欧元主权债券。年利达作为国际法律顾问为财政部提供服务;方达律师事务所作为联席主承销商中国法律顾问参与本次发行;A&O Shearman则为联席牵头经办人提供法律服务。

汉坤、君合、达维、高伟绅助力美团发行25亿美元债券(ZH/EN)

中国互联网本地商业平台美团成功发行25亿美元境外债券。汉坤律师事务所、达维律师事务所作为发行人律师参与交易;君合律师事务所、高伟绅律师事务所则为券商提供法律意见。

海问、凯易助力港交所18A企业第一宗反向收购案例(ZH/EN)

近日,港交所18A上市企业嘉和生物宣布与亿腾医药达成合并协议,合并后企业将更名为亿腾嘉和医药集团有限公司。海问律师事务所担任嘉和生物的法律顾问,凯易国际律师事务所则代表亿腾医药参与交易。